Step Therapy for Antidepressants: How "Fail First" Works
Save"Fail first" sounds informal, but it's a documented, specific process: a minimum trial length, a therapeutic dose range, and a recorded outcome, all reviewed before your insurer approves a non-preferred antidepressant. This article walks through what actually counts as failing a step, who documents it, and the exception paths that skip the requirement.
Last updated: July 2026
What exactly does step therapy require?
Step therapy is a formulary rule that sequences coverage: your plan pays for a preferred, usually lower-cost antidepressant first, and only covers a different, often more expensive medication after that first option has been tried and documented as inadequate. It's a form of utilization management insurers use across many drug classes, not something unique to psychiatric medication, though it shows up often here because several antidepressants are considered clinically interchangeable for a first trial 1Ref 1Centers for Medicare & Medicaid Services (2024).Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Advancing Interoperability and Improving Prior Authorization Processes (CMS-0057-F).prior-authorizationstep-therapypayer-policy. The federal push toward faster, more transparent electronic prior-authorization and step-therapy decisions has made plans disclose these sequences more clearly than in past years 1Ref 1Centers for Medicare & Medicaid Services (2024).Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Advancing Interoperability and Improving Prior Authorization Processes (CMS-0057-F).prior-authorizationstep-therapypayer-policy. In practice, your plan's formulary or prior-authorization criteria spell out which drug counts as "step one" for your diagnosis and plan tier -- worth requesting before assuming which medication qualifies.
What counts as "failing" a step?
Insurers typically define a failed trial with three elements: the medication was taken at a dose considered clinically adequate, for a minimum length of time considered long enough to judge effect, and the outcome was either insufficient improvement or a documented adverse reaction. Physician surveys have found that stacked step-therapy and prior-authorization requirements for psychiatric medications are a common source of treatment delay, which is part of why documentation quality matters so much at this stage 2Ref 2American Medical Association (2025).Prior authorization research & reports.prior-authorizationtreatment-delayphysician-survey. A trial that was interrupted early, underdosed, or undocumented often doesn't satisfy the requirement, even if it felt like a real attempt to you. If you've already been through a version of this trial with a medication you tried years ago, that history may still count, but only if it can be documented in your current chart.
Who documents the failed trial, and how?
Your prescriber's office typically documents the failed step, not you directly, using chart notes that record the drug, dose, duration, and outcome, then submits that documentation as part of the prior-authorization or step-therapy override request. This is why a phone call from you to the insurer rarely resolves a step-therapy denial on its own: the insurer is waiting on clinical documentation from the prescribing office, not a verbal account. Asking the office directly whether the prior trial was logged with enough detail -- dose, duration, and reason it didn't work -- is often the single most useful question you can ask, since incomplete documentation is a common reason these requests stall. If the office can also cite that an exception request already worked for a similar case, that history can speed the current one along.
Are there ways around step therapy entirely?
Yes, in a few specific circumstances. Most plans allow an exception request when a prescriber documents that the preferred step drug is contraindicated, was already tried in the past even with a different insurer, or poses a specific clinical risk for you. Some states also place additional limits on how step therapy can be applied to psychiatric medication specifically, such as maximum step counts or faster exception timelines, though rules vary widely by state. Mental health parity law separately requires that step-therapy and other utilization-management standards applied to behavioral health drugs be comparable to those applied to medical-surgical drugs, not stricter by default 3Ref 3Centers for Medicare & Medicaid Services (2024).The Mental Health Parity and Addiction Equity Act (MHPAEA).. Whether your specific state has one of these laws is worth checking directly, since it can change what your prescriber's office is able to request -- see state limits on step therapy for psychiatric medication.
When to loop in your prescriber's office
Because step therapy is resolved through clinical documentation, the most productive next step is usually a direct conversation with your prescriber's office about exactly what the insurer's criteria require and whether your history already satisfies them. Ask specifically whether the office has requested an exception for the antidepressant your doctor wants yet, what documentation it submitted, and how long the plan's decision window is expected to take. If the office hasn't yet framed the request as an exception -- rather than a fresh first-step trial -- flagging that distinction can be the detail that moves your case out of a routine queue and into one reviewed on its individual merits.
Common questions
Related
Psychiatric Medication, Practically
Do You Really Have to Fail Other Antidepressants First?Psychiatric Medication, Practically
Asking for a Step Therapy Exception: The Psychiatric Medication PlaybookPsychiatric Medication, Practically
State Step-Therapy Laws: The Limits Your Plan May Not Mention
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
If things feel heavy, a person is available anytime — call or text 988.
If a medication switch feels urgent
- —Worsening depression or anxiety symptoms during a step-therapy trial
- —New or returning thoughts of self-harm on a preferred-step medication
- —A gap in coverage that leaves you without any antidepressant while the review is pending
Step-therapy rules and exception criteria vary by plan and by state; this article describes general patterns, not your specific policy. This is general information, not medical or legal advice. If you are in crisis, call or text 988 (Suicide & Crisis Lifeline), free and available 24/7.
References
- 1.Centers for Medicare & Medicaid Services (2024). Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Advancing Interoperability and Improving Prior Authorization Processes (CMS-0057-F). Federal Register. link ✓prior-authorizationstep-therapypayer-policy
- 2.American Medical Association (2025). Prior authorization research & reports. American Medical Association (AMA). link ✓prior-authorizationtreatment-delayphysician-survey
- 3.Centers for Medicare & Medicaid Services (2024). The Mental Health Parity and Addiction Equity Act (MHPAEA). CMS (Centers for Medicare & Medicaid Services). link ✓
3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy